Orion Corporation, Orion Pharma
Clinical trials sponsored by Orion Corporation, Orion Pharma, explained in plain language.
-
New hope for advanced cancers: first human trial of ODM-212 begins
Disease control Recruiting nowThis study tests a new drug, ODM-212, in about 315 adults with advanced solid tumours that cannot be cured with current treatments. The trial has two parts: first finding a safe dose, then testing that dose in more people. The main goal is to check for side effects and see how th…
Phase: PHASE1, PHASE2 • Sponsor: Orion Corporation, Orion Pharma • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC
-
New drug combo targets tough cancers in early trial
Disease control Recruiting nowThis study tests a new drug called ODM-212 combined with other cancer treatments in people with advanced solid tumors, including mesothelioma, pancreatic cancer, and non-small cell lung cancer. The trial has two parts: first finding a safe dose, then checking how well it works. A…
Phase: PHASE1, PHASE2 • Sponsor: Orion Corporation, Orion Pharma • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC